MAP2K7 and breast carcinoma: It has previously suggested that IL-6 stimulated the proliferation of breast cancer cells mainly through the activation of STAT3 and cell migration through the activation of the RAS/MEK/ERK and PI3K/AKT signaling pathways [14].